MYX 0.81% $7.31 mayne pharma group limited

New Product Approvals, page-43

  1. 732 Posts.
    lightbulb Created with Sketch. 917
    Spot on Biggsy, this is a big problem with this company as I observe it. I am interested in investing in Mayne as I believe there may be some decent value to be extracted there (and a potential doubling of the share price) but they aren't giving enough reasons to do so right now. I have said it with other companies, it is not that hard to put out quality presentations as CSL does - it really is the benchmark in this regard.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$7.31
Change
-0.060(0.81%)
Mkt cap ! $617.6M
Open High Low Value Volume
$7.38 $7.40 $7.22 $367.0K 50.50K

Buyers (Bids)

No. Vol. Price($)
7 695 $7.30
 

Sellers (Offers)

Price($) Vol. No.
$7.32 278 4
View Market Depth
Last trade - 11.10am 06/05/2024 (20 minute delay) ?
Last
$7.30
  Change
-0.060 ( 0.28 %)
Open High Low Volume
$7.40 $7.40 $7.22 6166
Last updated 11.30am 06/05/2024 ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.